Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
San Francisco, CA
SEC filing record 1 source field available
Fiscal year end
31 December
TITAN PHARMACEUTICALS INC has filed 1,052 SEC EDGAR filings since 15 May 1996

SEC filing history

Showing 601-625 of 686 matching filings.

Per page
25
Current page
25
424B3 File 333-166351

FORM 424(B)(3)

Filing date
06 Jan 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-178656

EFFECT filing

Filing date
05 Jan 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-166351

EFFECT filing

Filing date
05 Jan 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

MAIN DOCUMENT DESCRIPTION

Filing date
05 Jan 2012
Reporting date
03 Jan 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

MAIN DOCUMENT DESCRIPTION

Filing date
05 Jan 2012
Reporting date
03 Jan 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

MAIN DOCUMENT DESCRIPTION

Filing date
05 Jan 2012
Reporting date
03 Jan 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

MAIN DOCUMENT DESCRIPTION

Filing date
05 Jan 2012
Reporting date
03 Jan 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

MAIN DOCUMENT DESCRIPTION

Filing date
05 Jan 2012
Reporting date
03 Jan 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

MAIN DOCUMENT DESCRIPTION

Filing date
05 Jan 2012
Reporting date
03 Jan 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

MAIN DOCUMENT DESCRIPTION

Filing date
05 Jan 2012
Reporting date
03 Jan 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-27436

FORM 8-K

Filing date
04 Jan 2012
Reporting date
30 Dec 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
POS AM File 333-166351

POST-EFFECTIVE AMENDMENT NO. 2 TO FORM S-1

Filing date
23 Dec 2011
Reporting date
Not listed
Next action
Verify source filing
S-3 File 333-178656

FORM S-3

Filing date
21 Dec 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-A12G File 000-27436

FORM 8-A12G

Filing date
21 Dec 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-27436

FORM 8-K

Filing date
21 Dec 2011
Reporting date
20 Dec 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-27436

FORM 8-K

Filing date
02 Dec 2011
Reporting date
01 Dec 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

MAIN DOCUMENT DESCRIPTION

Filing date
21 Nov 2011
Reporting date
18 Nov 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

MAIN DOCUMENT DESCRIPTION

Filing date
21 Nov 2011
Reporting date
18 Nov 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-27436

FORM 8-K

Filing date
17 Nov 2011
Reporting date
14 Nov 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-27436

FORM 8-K

Filing date
31 Oct 2011
Reporting date
25 Oct 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-27436

FORM 8-K

Filing date
17 Aug 2011
Reporting date
16 Aug 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q/A File 000-27436

AMENDMENT NO. 1 TO FORM 10-Q

Filing date
17 Aug 2011
Reporting date
30 Jun 2011
Next action
Verify source filing
10-Q File 000-27436

FORM 10-Q

Filing date
15 Aug 2011
Reporting date
30 Jun 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-166351

FILED PURSUANT TO RULE 424(B)(3)

Filing date
28 Jul 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .